Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic lymphocytic leukemia.

R L Stahl, R Silber

    Clinics in Geriatric Medicine
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Chronic lymphocytic leukemia (CLL) is a blood cancer marked by abnormal lymphocyte buildup. Prognosis depends on disease stage, bone marrow involvement, and genetic factors, with potential transformation to aggressive lymphoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Present results of the immunological study of the O virus that appeared in Austria in 1981.

    Revue scientifique et technique (International Office of Epizootics)·2020
    Same author

    Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

    Leukemia & lymphoma·2016
    Same author

    Peste Des Petits Ruminants in Benin: Persistence of a Single Virus Genotype in the Country for Over 42 Years.

    Transboundary and emerging diseases·2016
    Same author

    Full genome sequence of a peste des petits ruminants virus (PPRV) from Ghana.

    Virus genes·2014
    Same author

    First experiences with a combined usage of veno-arterial and veno-venous ECMO in therapy-refractory cardiogenic shock patients with cerebral hypoxemia.

    Perfusion·2013
    Same author

    Postoperative prognosis of pulmonary adenocarcinoma subtypes correlates with HLA-DR expression and the number of tumor-infiltrating cells.

    Oncology reports·2011
    Same journal

    Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

    Clinics in geriatric medicine·2026
    Same journal

    Preventive Cardiology for the Clinically Complex Older Adult.

    Clinics in geriatric medicine·2026
    Same journal

    A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

    Clinics in geriatric medicine·2026
    Same journal

    Secondary Prevention in Older Adults: Putting It All Together.

    Clinics in geriatric medicine·2026
    Same journal

    Primary Prevention in Older Adults: Putting It All Together.

    Clinics in geriatric medicine·2026
    Same journal

    Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

    Clinics in geriatric medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Molecular Biology

    Background:

    • Chronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm characterized by monoclonal lymphocyte accumulation.
    • Disease staging relies on lymphoid mass, anemia, and thrombocytopenia.
    • Prognostic indicators include bone marrow infiltration patterns, chromosomal abnormalities, and cell surface markers.

    Purpose of the Study:

    • To summarize the key pathological and prognostic features of chronic lymphocytic leukemia.
    • To highlight potential avenues for future clinical research based on described abnormalities.

    Main Methods:

    • Review of existing literature on chronic lymphocytic leukemia.
    • Analysis of staging criteria, prognostic factors, and disease progression pathways.

    Related Experiment Videos

  • Identification of biochemical and surface membrane abnormalities.

    • Main Results:

    • CLL involves the accumulation of monoclonal lymphocytes in blood, bone marrow, and lymphoid tissues.
    • Disease staging and prognosis are influenced by factors such as lymphoid mass, anemia, thrombocytopenia, bone marrow involvement, cytogenetics, and immunophenotype.
    • Terminal events can include transformation to diffuse large-cell lymphoma or prolymphocytic leukemia.

    Conclusions:

    • Chronic lymphocytic leukemia is a complex malignancy with diverse clinical presentations and prognoses.
    • Understanding prognostic factors is crucial for patient management and treatment strategies.
    • Identified biochemical and cellular abnormalities offer potential targets for novel therapeutic investigations.